|
Thursday, 07 August 2003 |
|
Amsterdam, 6 August 2003 - NIB Capital Private Equity and UCB, a Belgian listed pharmaceutical and specialty chemicals company, have agreed on the acquisition by NIB Capital Private Equity of the global Methylamines & Derivatives business of UCB for EUR 115 million.
|